Recent insights into Shigella: a major contributor to the global diarrhoeal disease burden

Journal article

Purpose of review Diarrhoea is a major global health problem, and recent studies have confirmed Shigella as a major contributor to this burden. Here, we review recent advances in Shigella research; focusing on their epidemiology, pathogenesis, antimicrobial resistance, and the role of the gut microbiome during infection.

Recent findings Enhanced epidemiological data, combined with new generation diagnostics, has highlighted a greater burden of Shigella disease than was previously estimated, which is not restricted to vulnerable populations in low-middle income countries. As we gain an ever more detailed insight into the orchestrated mechanisms that Shigella exploit to trigger infection, we can also begin to appreciate the complex role of the gut microbiome in preventing and inducing such infections. The use of genomics, in combination with epidemiological data and laboratory investigations, has unravelled the evolution and spread of various species. Such measures have identified resistance to antimicrobials as a key contributor to the success of specific clones.

Summary We need to apply novel findings towards sustainable approaches for treating and preventing Shigella infections. Vaccines and alternative treatments are under development and may offer an opportunity to reduce the burden of Shigella disease and restrict the mobility of antimicrobial resistant clones.

Authors: Baker, S; The, H

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Wolters Kluwer
• Journal: Current Opinion in Infectious Diseases
• Volume: 31
• Issue: 5
• Pages: 449–454
• Publication date: 2018-07-25
• Acceptance date: 2018-07-20
• DOI: 10.1097/QCO.0000000000000475
• EISSN: 1473-6527
• ISSN: 0951-7375
• Pmid: 30048255
• Language: English
• Keywords: genomics pathogenesis; Shigella; epidemiology; diarrhoeal disease